(Q41743574)

8 October 2017

1 reference

title

Insulin-dependent diabetes mellitus during alpha-interferon therapy for chronic viral hepatitis (English)

1 reference

8 October 2017

1 reference

Fabris P

1

1 reference

8 October 2017

Betterle C

2

1 reference

8 October 2017

Greggio NA

3

1 reference

8 October 2017

Zanchetta R

4

1 reference

8 October 2017

Bosi E

5

1 reference

8 October 2017

Biasin MR

6

1 reference

8 October 2017

de Lalla F

7

1 reference

8 October 2017

publication date

1 March 1998

1 reference

8 October 2017

published in

Journal of Hepatology

1 reference

8 October 2017

volume

28

1 reference

8 October 2017

issue

3

1 reference

8 October 2017

page(s)

514-517

1 reference

The pathogenesis of insulin-dependent diabetes mellitus

8 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980328-0

7 January 2021

Immunoreactive alpha-interferon in insulin-secreting beta cells in type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980328-0

7 January 2021

Induction of type I diabetes by interferon-alpha in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980328-0

7 January 2021

Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980328-0

7 January 2021

Onset of insulin-dependent diabetes mellitus after interferon-alfa therapy for hairy cell leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980328-0

7 January 2021

Occurrence of IDDM during interferon therapy for chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980328-0

7 January 2021

Diabetes Mellitus and Interferon-α Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980328-0

7 January 2021

Reversible diabetes in patient with AIDS-related Kaposi's sarcoma treated with interferon α-2a

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980328-0

7 January 2021

A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alfa interferon.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980328-0

7 January 2021

Side effects of high-dose interferon therapy for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980328-0

7 January 2021

10.1016/S0168-8278(98)80328-0

Identifiers

DOI

1 reference

8 October 2017

1 reference